STOCK TITAN

Precigen (PGEN) CCO granted 42,110 RSUs that vest immediately and convert to stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PRECIGEN, INC. Chief Commercial Officer Phil Tennant received a grant of 42,110 restricted stock units on March 18, 2026. Each RSU represents one share of common stock and vested immediately on the grant date. The RSUs were then exercised and converted into 42,110 shares of common stock at no cash exercise price, increasing his directly owned common stock holdings to 107,141 shares after these transactions. These actions reflect compensation-related equity awards and derivative exercises, not open-market buying or selling.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tennant Phil

(Last)(First)(Middle)
20374 SENECA MEADOWS PARKWAY

(Street)
GERMANTOWN MARYLAND 20876

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/18/2026M42,110A(1)107,141D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)03/18/2026A42,110 (2) (2)Common Stock42,110$042,110D
Restricted Stock Units(1)03/18/2026M42,110 (2) (2)Common Stock42,110$00D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
2. The RSUs vested immediately upon the grant date.
/s/ Phil Tennant, by Donald P. Lehr, as attorney-in-fact03/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity compensation did PGEN executive Phil Tennant receive?

Phil Tennant received 42,110 restricted stock units as equity compensation. Each RSU represents one share of Precigen common stock and vested immediately, reflecting a stock-based award rather than a cash bonus or open-market share purchase.

How many Precigen (PGEN) shares does Phil Tennant own after these transactions?

After these transactions, Phil Tennant directly owns 107,141 shares of Precigen common stock. This total includes 42,110 shares issued upon the immediate vesting and exercise of restricted stock units granted on March 18, 2026.

Were Phil Tennant’s recent PGEN transactions open-market purchases or sales?

These transactions were not open-market purchases or sales. They involved a grant of 42,110 restricted stock units that vested immediately and were exercised into common stock at a zero exercise price as part of compensation arrangements.

What does the immediate vesting of PGEN restricted stock units mean for Phil Tennant?

Immediate vesting means Tennant’s 42,110 restricted stock units became fully earned on the grant date. They were then promptly exercised into common stock, converting the contingent equity award into actual share ownership without a stated cash exercise cost.

Did Phil Tennant exercise any derivative securities of Precigen (PGEN)?

Yes. Tennant exercised 42,110 restricted stock units classified as derivative securities. These RSUs were converted into 42,110 shares of common stock, leaving no remaining RSU balance from this grant and increasing his direct common stock holdings.
Precigen Inc

NASDAQ:PGEN

View PGEN Stock Overview

PGEN Rankings

PGEN Latest News

PGEN Latest SEC Filings

PGEN Stock Data

1.17B
305.62M
Biotechnology
Pharmaceutical Preparations
Link
United States
GERMANTOWN